We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Clinical Robotics System Offers Automated Glucose Control and Continuous Blood Diagnostics in Critical Care and Surgery

By HospiMedica International staff writers
Posted on 08 Sep 2023

In critical care settings, metabolic parameters can undergo rapid and significant changes, often within minutes. More...

Accurately capturing and modeling this variability in real-time is a formidable challenge when done manually, and therapeutic decisions made without this precision carry substantial clinical risks. Furthermore, the scale of this challenge is substantial, with approximately 80% of critical care patients experiencing metabolic instability and the associated risks of glucose dysregulation. Properly controlling glucose levels is pivotal for tissue-level healing, especially for cardiovascular and surgical patients, as it reduces complications and enhances survivability. Historically, the manual workflow has been a limiting factor in achieving this level of control. Now, high-precision automation has changed this equation.

Admetsys Corporation (Boston, MA, USA) has developed an automated system for glucose control and continuous blood diagnostics that addresses a significant gap in the standard of care. This groundbreaking system automatically measures multiple blood analytes, including glucose, in real-time without the need for patient blood loss. It leverages this data to create an adaptive computational model of each patient's metabolism, which evolves alongside the patient's condition. The system then delivers precisely optimized treatment, including insulin and dextrose, through its multiple infusion channels.

The United States Food and Drug Administration (FDA) has designated Admetsys' automated glucose control and continuous blood diagnostics system as a Breakthrough Device. This designation expedites the system's path to market in the United States, a critical step considering the prevalence of cardiometabolic disorders in critical care settings. Hospitals in the U.S. are facing mounting challenges, including nursing shortages, increasing patient demand, and a focus on equitable access to high-quality care.

"The core of the system is its patient-adaptive learning algorithm. Machine intelligence using real-time biosensing data directly drives therapeutic actuation," said Admetsys CEO Jeff Valk. "This represents a new generation of device: fully autonomous clinical robotics."

"The system unlocks a previously unachievable mode of care. It affects this economically, at scale, while preserving focus for clinicians," added Valk. "Precision automation fundamentally changes the equation."

Related Links:
Admetsys Corporation 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Electrically Operated Patient Lifter
SVL 205
New
Instrument Cabinet
TRZY-068
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.